Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 25%
Hold 33%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc has demonstrated positive momentum in the behavioral health sector, highlighted by a 3% year-over-year increase in specialized admissions due to targeted referral initiatives at underperforming facilities. The company is on track to significantly increase its net PLGL liability to between $145-165 million by the end of 2025, up from $78 million at the close of 2024, indicating strong operational growth and resilience in an evolving regulatory landscape. Additionally, Acadia's strategy includes reducing capital expenditures by $300 million year-over-year in 2026, which is expected to substantially enhance cash flow and position the company favorably for future expansions and acquisitions.

Bears say

Acadia Healthcare Co Inc has lowered its full-year 2025 adjusted EBITDA guidance by $32.5 million to a range of $650-$660 million, citing ongoing volume softness, rate pressure, and higher-than-expected PLGL expenses. This marks a cumulative reduction of $94 million or 13.4% since the initial guidance was set, reflecting persistent challenges in reimbursement rates and demand for services. Additionally, the company's projections for 2026 have been revised downward, anticipating continued EBITDA pressures and elevated operational costs, which could adversely impact long-term profitability and stock valuation.

Acadia Healthcare (ACHC) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 25% recommend Buy, 33% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 12 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.